Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Month: April 2025

Home » Archives for April 2025 » Page 8
EAU25 | Final Survival Results from SPCG-13 Trial: Surveillance vs. Docetaxel After Radiotherapy in High-Risk Prostate Cancer

EAU25 | Final Survival Results from SPCG-13 Trial: Surveillance vs. Docetaxel After Radiotherapy in High-Risk Prostate Cancer

Posted by By Peter W. PENG 2025.04.15
In a Game Changer Session at EAU25, Prof. Kellokumpu-Lehtinen Pirkko-Liisa presented the 10-year follow-up from the Scandinavian Prostate Cancer Study Group-13 trial (SPCG-13), exploring adjuvant docetaxel versus surveillance following curative…
Read More
Can a short video ease the mind of a worried parent?

Can a short video ease the mind of a worried parent?

Posted by By Mourabit Halima 2025.04.15
At EAU25, Dr. Mehmet Cetin from Marmara University School of Medicine (Istanbul) presented a prospective randomized controlled study evaluating the impact of video-based informed consent on the anxiety levels of…
Read More
APASL China Voice | Dr. Rong Fan: The Application of Cell-Free DNA Testing in Early Hepatocellular Carcinoma Surveillance

APASL China Voice | Dr. Rong Fan: The Application of Cell-Free DNA Testing in Early Hepatocellular Carcinoma Surveillance

Posted by By Lisa Cui 2025.04.14
Editor’s Note: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. The overall prognosis for HCC remains poor, with a five-year…
Read More
APASL 2025 | Dr. Yinying Lu’s Team Unlocks New Multidimensional Strategies in Liver Cancer Treatment

APASL 2025 | Dr. Yinying Lu’s Team Unlocks New Multidimensional Strategies in Liver Cancer Treatment

Posted by By Mourabit Halima 2025.04.14
Editor’s Note: The 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2025) concluded successfully on March 30. Following the events in Beijing (2010)…
Read More
Allogeneic Transplant Outcomes in Severe Aplastic Anemia: What Role Does Donor Type Play?

Allogeneic Transplant Outcomes in Severe Aplastic Anemia: What Role Does Donor Type Play?

Posted by By Mourabit Halima 2025.04.14
At the EBMT 2025 Annual Meeting, Dr. Juan Montoro Gómez (La Fe University and Polytechnic Hospital, Valencia) presented key findings from a comparative study led by the SAAWP of the…
Read More
Relapsed B-ALL Post CAR-T Therapy: Addressing a Growing Clinical Challenge | EBMT 2025

Relapsed B-ALL Post CAR-T Therapy: Addressing a Growing Clinical Challenge | EBMT 2025

Posted by By Mourabit Halima 2025.04.14
In his EBMT 2025 presentation, Prof. Alessandro Rambaldi (University of Milan / ASST Papa Giovanni XXIII, Bergamo) offered valuable insight into one of the most pressing issues in hematologic oncology:…
Read More
Late Effects After Auto-HSCT in Autoimmune Diseases: A Call for Long-Term Monitoring

Late Effects After Auto-HSCT in Autoimmune Diseases: A Call for Long-Term Monitoring

Posted by By Peng Longmei 2025.04.14
At the EBMT 2025 annual meeting, Dr. Kirill Kirgizov presented findings from a comprehensive retrospective survey (GS2-10) on late complications following autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases…
Read More
Clonal Hematopoiesis in Pediatric HCT Survivors: New Insights from Dr. Konradin Müskens at EBMT 2025

Clonal Hematopoiesis in Pediatric HCT Survivors: New Insights from Dr. Konradin Müskens at EBMT 2025

Posted by By Mourabit Halima 2025.04.13
At the 51st EBMT Annual Meeting, Dr.Konradin Müskens (Prinses Máxima Centrum voor kinderoncologie, Netherlands) presented findings from the GS2-4 session on “Prevalence and Origin of Clonal Hematopoiesis in Long-Term Survivors…
Read More
Understanding Relapse After Allo-HCT: Dr. Luca Vago Sheds Light on Biological Complexity and Future Solutions

Understanding Relapse After Allo-HCT: Dr. Luca Vago Sheds Light on Biological Complexity and Future Solutions

Posted by By Peng Longmei 2025.04.13
At EBMT 2025, Dr. Luca Vago delivered a compelling presentation titled “Mechanisms of Leukemia Relapse after Allogeneic Transplantation: From Biology to Treatment (and Back).” His talk focused on the intricate…
Read More
Predicting Graft Failure in Pediatric HCT: Key Insights from EBMT 2025

Predicting Graft Failure in Pediatric HCT: Key Insights from EBMT 2025

Posted by By Lisa Cui 2025.04.13
At the 51st Annual Meeting of EBMT, Dr. Rawad Rihani from the King Hussein Cancer Center (Jordan) delivered an important presentation on the determinants and outcomes of graft failure (GF)…
Read More

Posts pagination

Previous page 1 … 6 7 8 9 10 … 14 Next page
Recent Posts
  • Professor Dingwei Ye: Building an Authoritative Academic Platform in Uro-Oncology and Driving Continuous Progress in Urothelial Carcinoma Management |
  • Professor Hao Zeng’s Team Publishes in JAMA Oncology: Innovative First-Line Immunotherapy Approach for Advanced FH-Deficient Renal Cell Carcinoma
  • AI-Driven Imaging Breakthrough in CAR-T Therapy丨Professor Stephen Schuster on Predicting Efficacy
  • Polatuzumab Improves Survival in Relapsed/Refractory DLBCL丨Phase III POLARGO Study Highlights
  • Breakthrough Discovery of LymphoMAPs in Large B-cell Lymphoma丨Professor David Russler-Germain on CAR T Therapy
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司（香港）
    Scroll to Top